Ferrosa Therapeutics AG ("FERROSA"), a Swiss biotechnology company developing a first-in-class bispecific antibody to treat ...
Cambridge researchers have opened a new phase in our understanding of autoimmune diseases by suggesting they may be driven by ...
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity ...
Reproductive health counseling by rheumatologists is inconsistently delivered to women with systemic autoimmune disease.
Palindromic rheumatism often begins with hand and shoulder involvement, and patients who progress to persistent inflammatory ...
Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...
Temporomandibular joint disorders (TMDs) affect a large portion of the global population and are a common source of chronic ...
Emphasizing how biological factors, rather than lifestyle choices, cause gout can impact patients’ opinions on long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results